Nifty Pharma Prediction for Tomorrow, Thursday 6 August 2026: Index at 21,845 Recovers 1.0% as Dr Reddy's Shock Absorbed and Sun Pharma Firms

The Nifty Pharma prediction for tomorrow for Thursday 6 August 2026 is framed by Wednesday's session where Brent crude extended its weekly decline to 78.44 US dollars, down 12 percent in a single week on Iran deal mediators in Qatar reporting progress, while the RBI held rates at 5.25 percent with a neutral stance. Nifty 50 closed approximately flat near 24,590 while Sensex gained 321 points to approximately 78,750 — a historic divergence driven by the new Closing Auction Session mechanism. Bank Nifty fell 187 points to approximately 57,720 as private banks (HDFC Bank -1.13 percent, ICICI Bank -1.07 percent) underperformed while PSU banks (SBI +0.86 percent) outperformed ahead of SBI Q1 FY27 results on Thursday. The Nifty Pharma is the sectoral benchmark for Thursday. The Nifty Pharma prediction for tomorrow for Thursday balances three catalysts: the weekly Nifty options expiry, SBI Q1 FY27 results and Brent crude at 78.44 US dollars. Nifty Pharma recovered 1.0 percent Wednesday as Dr Reddy's Q1 FY27 sell-off from Tuesday (which had taken the index down 1.0 percent) partially reversed with stabilisation buying. Sun Pharma, the largest constituent with strong own Q1 results (+27 percent PAT), anchored the Nifty Pharma prediction for tomorrow recovery. Aurobindo Pharma Q1 FY27 results announced Wednesday evening will be the next sector-specific catalyst for Thursday on Thursday. Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, present the complete Nifty Pharma prediction for tomorrow.

Click Here – Get Free Investment Predictions

Wednesday's Data Behind the Nifty Pharma prediction for tomorrow

Indicator	Wednesday 5 Aug Close	Change
Nifty Pharma	21,845	+1.0%
Day Range	21,720-21,930	Session high/low
Nifty 50	~24,590	~-25 pts (-0.10%) — CAS divergence
Sensex	~78,750	+321 pts (+0.41%) — Grasim, L&T led
Bank Nifty	~57,720	-187 pts (-0.32%) — private banks lagged
India VIX	~11.48	Down from 12.19 (RBI event resolved)
Brent Crude	$78.44/bbl	-$0.92 (-1.2%) today; -12% weekly
SBI Q1 FY27	Results due Thursday Aug 6	SBI +0.86% Wed on pre-result positioning

Ankit Jaiswal notes the Nifty Pharma prediction for tomorrow is shaped by three simultaneous forces: crude at 78.44 US dollars (the structural positive for FMCG, Realty, Cement and Auto that drove Wednesday's outperformers up 1-2 percent), the weekly Nifty options expiry on Thursday (intraday volatility guarantee), and SBI Q1 FY27 results (the binary banking catalyst). The Nifty Pharma is the sectoral benchmark for Thursday. The Nifty Pharma prediction for tomorrow analysis below maps each catalyst to its impact on Thursday's likely range and direction.

Technical Levels for the Nifty Pharma prediction for tomorrow

Level Type	Zone
Immediate Support	21,700-21,750
Support 2	21,400-21,450
Strong Support	20,900-21,000 (50 DMA)
Immediate Resistance	22,050-22,150
Key Resistance	22,400-22,600

Kunal Singla observes that the Nifty Pharma prediction for tomorrow enters Thursday with VIX at 11.48, the lowest since Monday August 3, confirming option writers are pricing a calmer session after Wednesday's RBI-driven volatility resolved. The weekly expiry pin near the max pain zone for Thursday creates a gravitational force for the first 90 minutes of Thursday's session before SBI Q1 result catalysts take over. 22,050-22,150 is the primary resistance that the Nifty Pharma prediction for tomorrow must clear for the bullish case to be confirmed post-SBI results.

Iran Deal and Crude at $78.44: Core Driver of the Nifty Pharma prediction for tomorrow

Brent crude at 78.44 US dollars is the most significant macro variable for Thursday. Qatar, Pakistan and Oman continued shuttle diplomacy between Washington and Tehran on Wednesday, with mediators reporting progress in narrowing differences. The Strait of Hormuz remains partially shut with another vessel attacked Wednesday, maintaining 1-2 US dollars of risk premium in crude. Ankit Jaiswal tracks three crude scenarios for Thursday: formal Iran deal overnight pushes Brent to 72-75 US dollars (very bullish for FMCG, Realty, Auto, Cement in this outlook); status quo at 78-80 US dollars is the base case; deal collapse pushes Brent back above 84 US dollars (bearish for FMCG and FMCG-linked sectors in this outlook).

Key Factors Shaping the Nifty Pharma prediction for tomorrow

• The Nifty Pharma prediction for tomorrow benefits from Tuesday's Dr Reddy's shock having been partially absorbed by Wednesday's 1.0 percent recovery. Stabilisation buying indicates the sector is not broadening its Q1 miss beyond Dr Reddy's.
• Sun Pharma's 27 percent Q1 net profit growth continues to anchor the Nifty Pharma prediction for tomorrow as the largest and most fundamentally positive constituent.
• Aurobindo Pharma Q1 FY27 results announced Wednesday evening will be the next pharma-specific catalyst. A strong Aurobindo result would push the Nifty Pharma prediction for tomorrow bullishly toward 22,050-22,150.

Stocks to Watch in the Nifty Pharma prediction for tomorrow

Univest analysts flag the following stocks for educational observation in this outlook on Thursday. These are not buy recommendations.

Sun Pharma: CMP Rs 1,780. Ankit Jaiswal flags entry Rs 1,762-1,778, target Rs 1,828, SL Rs 1,734. Sun Pharma's 27 percent Q1 PAT growth anchors the Nifty Pharma prediction for tomorrow with fundamental support. This is a watch in this outlook.

Cipla: CMP Rs 1,642. Kunal Singla flags entry Rs 1,622-1,640, target Rs 1,692, SL Rs 1,596. Cipla's diversified India and US portfolio provides broad Nifty Pharma prediction for tomorrow coverage beyond any single company's Q1 miss. This is a watch in this outlook.

Apollo Hospitals: CMP Rs 8,910. Ankit Jaiswal flags entry Rs 8,820-8,900, target Rs 9,150, SL Rs 8,680. Apollo Hospitals provides domestic healthcare demand insulation from US generic drug pricing risks in this outlook. This is a watch in this outlook.

Use the Univest Screener to Track the Nifty Pharma prediction for tomorrow Live on Thursday

Trading Strategy for the Nifty Pharma prediction for tomorrow

1. 21,700-21,750 is the support for Thursday.
2. 22,050-22,150 is the first resistance in this outlook. Ankit Jaiswal recommends booking here.
3. Monitor Aurobindo Pharma results (due today evening) for the primary Thursday catalyst in this outlook.
4. Watch Sun Pharma opening as the bellwether for Thursday direction.

Risks to the Nifty Pharma prediction for tomorrow

• Aurobindo Pharma Q1 FY27 disappointing on US generic pricing creating renewed sector-specific selling in this outlook.
• US FDA warning letters on Indian pharma manufacturing plants creating sector headwinds in this outlook.
• Rupee strengthening reducing US generic export realizations across the Nifty Pharma prediction for tomorrow.

Conclusion

The Nifty Pharma prediction for tomorrow for Thursday 6 August 2026 is shaped by +1.0% to 21,845 on Wednesday, driven by Brent crude at 78.44 US dollars on Iran deal progress. Ankit Jaiswal of Univest identifies 22,050-22,150 as the key resistance and 21,700-21,750 as the critical support for the Nifty Pharma prediction for tomorrow. SBI Q1 FY27 results on Thursday and the weekly Nifty options expiry are the twin catalysts that define the Nifty Pharma prediction for tomorrow direction for August 6. A strong SBI Q1 beat would be the most powerful positive catalyst for the Nifty Pharma prediction for tomorrow in Thursday's session.

Kunal Singla of Univest notes that with India VIX at 11.48, the Nifty Pharma prediction for tomorrow carries lower volatility expectations than Tuesday's pre-RBI setup. The crude-below-80-dollar structural theme (Realty +2%, Auto +1.1%, Cement +1.1% on Wednesday) provides the positive sector underpinning for the Nifty Pharma prediction for tomorrow even if banking remains under PSU-versus-private rotation pressure on Thursday.

Download the Univest iOS App or Univest Android App to track live levels and SBI Q1 result alerts for the Nifty Pharma prediction for tomorrow.

FAQs on Nifty Pharma Prediction For Tomorrow

What is the Nifty Pharma prediction for tomorrow, Thursday 6 August 2026?

Ans. The Nifty Pharma prediction for tomorrow is neutral-to-bullish. Nifty Pharma recovered 1.0 percent Wednesday to 21,845, absorbing Tuesday's Dr Reddy's shock. Support is 21,700-21,750 and resistance 22,050-22,150. Aurobindo Pharma Q1 results on Thursday are the next sector catalyst for the Nifty Pharma prediction for tomorrow.

Which analysts prepared the Nifty Pharma prediction for tomorrow?

Ans. Ankit Jaiswal, Senior Research Analyst, and Kunal Singla, Associate Director at Univest, prepared the Nifty Pharma prediction for tomorrow.

Has Dr Reddy's impact faded in the Nifty Pharma prediction for tomorrow?

Ans. Wednesday's 1.0 percent recovery suggests the Dr Reddy's shock has been largely absorbed. The Nifty Pharma prediction for tomorrow now depends on whether Aurobindo Pharma Q1 results extend the sector stress or provide a counterbalancing positive.

What is Nifty Pharma support and resistance for the prediction for tomorrow?

Ans. Support is 21,700-21,750 and 21,400-21,450. The 50 DMA at 20,900-21,000 is the floor. Resistance is 22,050-22,150 and 22,400-22,600 in this outlook.

What stocks are watched in the Nifty Pharma prediction for tomorrow?

Ans. Sun Pharma (strong Q1 anchor), Cipla (diversified exposure) and Apollo Hospitals (domestic demand insulation) are the three stocks in this outlook.